Inoca International
Dec 14, 2025, 12:49
Predicting Thrombosis and Bleeding in Cancer․ The Role of Inflammatory and Cardiac Biomarkers
Filippo Crea, European Heart Journal Editor-in-Chief, posted on X:
”Inflammatory and cardiac biomarkers help predict venous thromboembolism and bleeding risk in cancer patients. Toward smarter risk stratification.”
Read the full Article here.
Title: Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
Authors: Danielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, Dylan Burger, Marc Carrier, Philip Wells, Steven Hawken
Stay updated with Hemostasis Today.
-
May 13, 2026, 07:35Ifeanyichukwu Ifechidere: Why DIC is the Condition That Humbles even the Most Experienced Scientists
-
May 13, 2026, 07:26Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
-
May 13, 2026, 07:09Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
-
May 13, 2026, 06:48Akshat Jain: Transforming Sickle Cell Care With Practical Apheresis Frameworks
-
May 13, 2026, 06:35Dima Shulkin: How Neutrophil Extracellular Traps Shape ACS
-
May 13, 2026, 05:50Danny Hsu: Global Maternal VTE Awareness and Opportunities for Prevention
-
May 13, 2026, 05:50Ney Carter Borges: Clinical Cardiovascular Polygenic Risk Report for 8 Conditions
-
May 13, 2026, 05:49Kalyan Roy: A New Blood Group System Has Been Discovered
-
May 13, 2026, 05:07Azin Alizadehasl: Unraveling DIC in Cancer-Driven Coagulopathy